Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:RDHL
Date1/2013
Raised
Post IPO Valuation

General Information

Offices

Ramat-Gan, ISR
42 Givati St.
Ramat-Gan, 52232, ISR

People

CEO, Director

Funding

TOTAL $30.2M
FUNDING TOTAL $30.2M
Venture Round, 11/2010
$10M
Venture Round, 12/2013
OrbiMed Advisors
Broadfin Capital
$8.5M
Venture Round, 1/2014
Yelin Lapidot Investment House
Excellence Nessuah
Sphera Global Healthcare Master Fund
Migdal Insurance and Financial Holdings Ltd.
$11.7M

Tags

RedHill Biopharma

RedHill Biopharma, established in 2009, is a pharmaceutical company focused primarily on acquisition and development of late clinical-stage new, improved and patented formulations of existing drugs, with preference to a 505(b)(2)* regulatory paths, as well as acquisition and developement of late clinical-stage, new and patented orphan drugs.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. RedHill Biopharma Raises over $10M from Local and Foreign Investors (finsmes.com) [edit]
  2. RedHill Biopharma closes $8.5 million private placements from OrbiMed Israel Partners and Broadfin Capital (redhillbio.com) [edit]
  3. RedHill Biopharma raises $11.7m in private placement (globes.co.il) [edit]
Edit This Page
Last Edited 1/23/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy